Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Diagonal Bio

Less than 1K followers
Overview
Investor consensus
All
Press releases
ShowingAll content types
Regulatory press release12/11/2025, 12:50 PM

Diagonal Bio has been declared in bankruptcy

Diagonal Bio
Regulatory press release12/11/2025, 9:45 AM

Diagonal Bio intends to submit a formal application for bankruptcy

Diagonal Bio
Regulatory press release12/1/2025, 7:30 AM

Nomination Committee appointed for Diagonal Bio

Diagonal Bio

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release11/4/2025, 8:30 AM

Untersteiner Racing signs agreement for a pilot test

Diagonal Bio
Regulatory press release10/31/2025, 7:00 AM

Diagonal Bio publishes interim report for the third quarter of 2025

Diagonal Bio
Press release10/13/2025, 7:00 AM

Diagonal Bio launches new website to reflect commercial focus on the Animal Health segment

Diagonal Bio
Press release10/3/2025, 9:30 AM

Diagonal Bio initiates collaboration with SVA on evaluation of coronavirus in horses

Diagonal Bio
Regulatory press release9/23/2025, 9:15 AM

Diagonal Bio expands horse testing panel to detect Equine Herpesvirus type 2

Diagonal Bio
Regulatory press release9/18/2025, 11:00 AM

Diagonal Bio receives order from Stall Courant

Diagonal Bio
Regulatory press release8/22/2025, 6:00 AM

Diagonal Bio publishes interim report for the second quarter of 2025

Diagonal Bio
Press release8/20/2025, 6:00 AM

Diagonal Bio AB receives patent approval in Japan

Diagonal Bio
Press release7/7/2025, 11:00 AM

Diagonal Bio AB files patent application for Novel Computational Method that significantly improves LAMP primer design

Diagonal Bio
Regulatory press release6/25/2025, 11:00 AM

The Board of Directors of Diagonal Bio carries out a directed issue to underwriters in connection with exercise of warrants of series TO 2

Diagonal Bio
Regulatory press release6/19/2025, 11:40 AM

Diagonal Bio receives SEK 3.6 million through exercise of warrants of series TO 2

Diagonal Bio
Regulatory press release6/17/2025, 4:47 PM

Update regarding large shareholder’s exercise of warrants of series TO 2

Diagonal Bio
Regulatory press release6/17/2025, 6:30 AM

Diagonal Bio expands equine panel with addition of strangles

Diagonal Bio
Regulatory press release6/16/2025, 6:30 AM

Large shareholder exercises warrants of series TO 2

Diagonal Bio
Regulatory press release6/13/2025, 6:00 AM

Last day of trading in Diagonal Bio’s warrants of series TO 2 is 16 June 2025

Diagonal Bio
Press release6/11/2025, 9:30 AM

Diagonal Bio shares progress update on LAMPlify® commercial pilots

Diagonal Bio
Regulatory press release6/9/2025, 12:00 PM

Svea Bank AB invests SEK 0.5 million in Diagonal Bio AB through the exercise of warrants of series TO 2

Diagonal Bio
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.